References
- Osborne R, Joel S, Trew D, et al. Morphine and metabolite behavior after different routes of morphine administration: demonstration of the importance of the active metabolite morphine-6-glucuronide. Clin Pharmacol Ther. 1990;47:12–19.
- Faura CC, Collins SL, Moore RA, et al. Systematic review of factors affecting the ratios of morphine and its major metabolites. Pain. 1998;74:43–53.
- Somogyi AA, Nation RL, Olweny C, et al. Plasma concentrations and renal clearance of morphine, morphine-3-glucuronide and morphine-6-glucuronide in cancer patients receiving morphine. Clin Pharmacokinet. 1993;24:413–420.
- Office for National Statistics. Deaths related to drug poisoning where any opiates were mentioned on the death certificate, local authorities in England and Wales, 1993 to 2016. [Cited 2018 Oct 10]. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/adhocs/007446deathsbydrugpoisoningwhereanyopiateswerementionedonthedeathcertificatelocalauthoritiesinenglandandwales1993to2016
- Garriott JC, Sturner WQ. Morphine concentrations and survival periods in acute heroin fatalities. N Engl J Med. 1973;289:1276–1278.
- Goldberger BA, Cone EJ, Grant TM, et al. Disposition of heroin and its metabolites in heroin-related deaths. J Anal Toxicol. 1994;18:22–28.
- Aderjan R, Hofmann S, Schmitt G, et al. Morphine and morphine glucuronides in serum of heroin consumers and in heroin-related deaths determined by HPLC with native fluorescence detection. J Anal Toxicol. 1995;19:163–168.
- Pounder DJ, Jones GR. Post-mortem drug redistribution-a toxicological nightmare. Forensic Sci Int. 1990;45:253–263.
- Leikin J, Watson W. Post-mortem toxicology: what the dead can and cannot tell us. J Toxicol Clin Toxicol. 2003;41:47–56.
- Pélissier-Alicot A-L, Gaulier JM, Champsaur P, et al. Mechanisms underlying postmortem redistribution of drugs: a review. J Anal Toxicol. 2003;27:533–544.
- Flanagan RJ, Connally G. Interpretation of analytical toxicology results in life and at postmortem. Toxicol Rev. 2005; 24:51–56.
- Ferner RE. Post-mortem clinical pharmacology. Br J Clin Pharmacol. 2008;66:430–443.
- Gerostamoulos J, Drummer OH. Postmortem redistribution of morphine and its metabolites. J Forensic Sci. 2000;45:843–845.
- Crandall CS, Kerrigan S, Aguero RL, et al. The influence of collection site and methods on postmortem morphine concentrations in a porcine model. J Anal Toxicol. 2006;30:651–658.
- Maskell PD, Albeishy M, De Paoli G, et al. Postmortem redistribution of the heroin metabolites morphine and morphine-3-glucuronide in rabbits over 24 h. Int J Legal Med. 2016; 130:519–531.
- Peters F, Drummer O, Musshoff F. Validation of new methods. Forensic Sci Int. 2007; 165:216–224.
- British Standard EN ISO/IEC 17025:2017 General requirements for the competence of testing and calibration laboratories Published : December 2017.
- Jantos R, Schuhmacher M, Veldstra JL, et al. Determination of blood/serum ratios of different forensically relevant analytes in authentic samples. Arch Kriminol. 2011; 227:188–203.
- Vassar Stats. [cited 16 Oct 2018]. Available from: http://vassarstats.net/wilcoxon.html
- Cook DS, Braithwaite RA, Hale KA. Estimating antemortem drug concentrations from postmortem samples: the influence of postmortem drug redistribution. J Clin Pathol. 2000;53:282–285.
- Tolliver SS, Hearn WL, Furton KG. Evaluating the relationship between postmortem and antemortem morphine and codeine concentrations in whole blood. J Anal Toxicol. 2010;34:491–497.
- Skopp G, Pötsch L, Klingmann A, et al. Stability of morphine, morphine-3-glucuronide, and morphine-6-glucuronide in fresh blood and plasma and postmortem blood samples. J Anal Toxicol. 2001;25:2–7.
- Hayward V, Ledbetter S, Button J, et al. Interpretation of morphine concentrations in trauma cases. [cited 17 Oct 2018]. Available from: http://www.the-ltg.org/data/uploads/posters/morphine.pdf.